Quick-Med Technologies, a life sciences company, has received clearance from the FDA to market and distribute its patented Nimbus barrier gauze wound care dressings.
Subscribe to our email newsletter
According to the company, this represents the first FDA clearance for Nimbus – a technology that is so unique and that it was put through FDA’s de novo process.
Anticipating FDA clearance, Quick-Med has already licensed Nimbus gauze for marketing in the US and Canada to Derma Sciences, a provider of advanced wound care products. Derma Sciences and the company expect the product to launch in spring, 2009.
The company is actively negotiating with other medical device manufacturers for application of nimbus to other substrates.
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.